Akorn, Inc. (Nadaq: AKRX) announced that it has acquired from Merck (NYSE: MRK), the U.S. rights to three branded ophthalmic ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE